Dr. Suman Kambhampati
Claim this profileResearch Medical Center
Affiliated Hospitals
Research Medical Center
HCA Midwest
Clinical Trials Suman Kambhampati is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
Iberdomide vs Lenalidomide
for Multiple Myeloma
This trial is testing two treatments, iberdomide and lenalidomide, to see which one is better at preventing cancer from coming back in patients with newly diagnosed multiple myeloma after a stem cell transplant. These treatments help the immune system fight off cancer cells. Lenalidomide has been used for the treatment of multiple myeloma, showing effectiveness and improving survival outcomes.
Recruiting
2 awards
Phase 3
More about Suman Kambhampati
Clinical Trial Related
6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Suman Kambhampati has experience with
- Dexamethasone
- Venetoclax
- Lenalidomide
- Bortezomib
- Azacitidine
- Iberdomide
Breakdown of trials Suman Kambhampati has run
Multiple Myeloma
Acute Myelogenous Leukemia
Lymphoma
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suman Kambhampati specialize in?
Suman Kambhampati focuses on Multiple Myeloma and Acute Myelogenous Leukemia. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Suman Kambhampati currently recruiting for clinical trials?
Yes, Suman Kambhampati is currently recruiting for 3 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Suman Kambhampati has studied deeply?
Yes, Suman Kambhampati has studied treatments such as Dexamethasone, Venetoclax, Lenalidomide.
What is the best way to schedule an appointment with Suman Kambhampati?
Apply for one of the trials that Suman Kambhampati is conducting.
What is the office address of Suman Kambhampati?
The office of Suman Kambhampati is located at: Research Medical Center, Kansas City, Missouri 64132 United States. This is the address for their practice at the Research Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.